Related Experiment Video
Updated: Feb 14, 2026

Application of Ultrasound and Shear Wave Elastography Imaging in a Rat Model of NAFLD/NASH
Published on: April 20, 2021
Quantifying Effect of Onabotulinum Toxin A on Passive Muscle Stiffness in Children with Cerebral Palsy Using
Joline E Brandenburg1, Sarah F Eby, Pengfei Song
1From the Department of Physical Medicine and Rehabilitation (JEB), Department of Neurology (JEB), Department of Pediatric and Adolescent Medicine (JEB), Mayo Graduate School, Medical Scientist Training Program, Mayo Clinic College of Medicine (SFE), Department of Radiology (PS), Department of Health Sciences Research (WRB), Department of Physiology and Biomedical Engineering (GCS, K-NA), and Division of Orthopedic Research (K-NA), Mayo Clinic, Rochester, Minnesota.
Insights
Onabotulinum toxin A (BoNT-A) temporarily improved passive muscle properties in children with cerebral palsy, as measured by shear wave elastography. These effects on muscle stiffness resolved by three months post-injection.
Area of Science:
- Biomedical Engineering
- Pediatric Neurology
- Rehabilitation Medicine
Background:
- Cerebral palsy (CP) often leads to muscle spasticity and altered passive muscle properties.
- Onabotulinum toxin A (BoNT-A) is used to manage spasticity in children with CP.
- Quantifying the direct effects of BoNT-A on muscle tissue properties is crucial for understanding treatment efficacy.
Purpose of the Study:
- To longitudinally assess the impact of onabotulinum toxin A (BoNT-A) on passive muscle properties in children with cerebral palsy.
- To utilize ultrasound shear wave elastography (SWE) as a tool to measure changes in muscle stiffness.
- To correlate changes in muscle properties with clinical outcomes.
Main Methods:
- A prospective longitudinal cohort study design was employed.
- Ultrasound shear wave elastography (SWE) was used to measure the shear modulus of the lateral gastrocnemius muscle.
- Measurements were taken before and at 1 and 3 months after BoNT-A injections in pediatric patients with CP.
Main Results:
- A significant reduction in the shear modulus (indicating decreased stiffness) of the lateral gastrocnemius was observed at 1 month post-BoNT-A at 10-degrees and 0-degrees plantar flexion (P = 0.02 and P = 0.03, respectively).
- No significant differences in passive range of motion or spasticity scores were detected between pre-injection and post-injection time points.
- The observed changes in shear modulus were not significantly different from baseline values by 3 months post-BoNT-A, suggesting a temporary effect.
Conclusions:
- Ultrasound shear wave elastography can detect changes in passive muscle properties following BoNT-A treatment in children with cerebral palsy.
- The observed improvements in muscle stiffness are transient, resolving by 3 months post-injection.
- While BoNT-A may alter muscle mechanical properties, its impact on passive range of motion and spasticity in this cohort was not significant within the study period.
Objective:
A pilot study was conducted to longitudinally quantify effect of onabotulinum toxin A (BoNT-A) on passive muscle properties in children with cerebral palsy using ultrasound shear wave elastography.
Design:
This was a prospective longitudinal cohort study.
Results:
Between 1 and 3 mos post-BoNT-A, a significant improvement in the shear modulus of the lateral gastrocnemius was found at 10-degrees plantar flexion (PF) (-7.57 [-10.98, -5.07], P = 0.02) and 0-degrees PF (-14.74 [-18.21, -9.38], P = 0.03). There was a notable, but nonsignificant, difference in shear modulus at 20-degrees PF, 10-degrees PF, and 0-degrees PF between pre-BoNT-A and 1 mo post-BoNT-A. Pre-BoNT-A shear modulus was not significantly different from 3 mos post-BoNT-A at all foot positions. No significant differences in ankle passive range of motion or spasticity were found.
Conclusion:
Despite no significant change in ankle range of motion or spasticity, shear wave elastography was able to detect a difference in lateral gastrocnemius passive muscle properties in children with cerebral palsy after BoNT-A injections. The difference in passive muscle properties resolved by 3 mos post-BoNT-A.
More Related Videos
07:20Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
Published on: August 9, 2024
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Related Concept Videos
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Types of Toxins
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Passive Filters
Low-Pass Filters
Low-pass filters are designed to transmit signals with frequencies lower than the cutoff frequency, ωc, and attenuate those above it. The cutoff...
The Wave Nature of Light
Shear Diagram
First, a free-body diagram of the beam is drawn, representing all the external forces and internal reactions acting on the beam. One can calculate the reaction forces at each support by employing the equilibrium equations of force and moment. The vertical component...
Shearing Stress
The average shearing stress can be calculated by dividing the shear by the area of the cross-section.